This is the second in our regular round-ups of recent news items on homeopathy and anthroposophic medicine. We provide links and background to some of the recent news stories of relevance to the public debate about our sector.
RSS feed
Political affairs, new report on first safe dilution and advocacy pack
Position paper on NtA, Volume 2A, Chapter 1, Rev. 4 from June 2013, section 3.3
CV Pannenbecker
Legal statement to Echamp Braille 02Oct2013 (1)
Summary on HMPWG First Safe Dilutions consultations
The October 2015 issue of ‘Homeopathy’ is dedicated to a special review of the status quo of research into ultra high dilutions, showing how researchers around the world are investigating the mechanism of action of homeopathic medicines.
HMPWG has updated its safety guidance on homeopathic medicinal products from biological origin, outlining the requirements to be fulfilled by these medicinal products in the registration procedure.
The Homeopathic Medicinal Products Working Group (HMPWG) of the Heads of Medicines Agencies has launched a public consultation on the safety of homeopathic medicinal products from biological origin. The original guideline were adopted in 2007; a revised version has now been published for consultation.
Description
Sector scientists and other experts joined ECHAMP members and interested Swedish stakeholders in Stockholm for a lively discussion on the current and future scientific and political context for homeopathic and anthroposophic medicinal products.
ECHAMP welcomes DGC Nordic as a new full member; its next Membership Assembly will be held in Berlin in April 2017, chaired by Mathias Hevert, Board member of ECHAMP and Managing Director of Hevert Arzneimittel.
Membership Assembly 2016, MEPs' meeting and project group on homeopathic and anthroposophic medicinal products that cannot be registered by the simplified procedure (art. 14.1)
New project 2016, answers to HMPWG and EDQM consultations